FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036457434> ?p ?o ?g. }

• W3036457434 endingPage "5706" @default.
• W3036457434 startingPage "5700" @default.
• W3036457434 abstract "To prevent premature dismissal of promising vaccine programs, it is critical to determine if lack of efficacy in the field is due to allele specific-efficacy, rather than to the lack of immunogenicity of the candidate antigen. Here we use samples collected during a field trial of the AMA1-based FMP2.1/AS02A malaria vaccine, which incorporates the AMA1 variant encoded by the reference Plasmodium falciparum 3D7 strain, to assess the usefulness of epitope-based sieve analysis for the detection of vaccine-induced allele-specific immune responses. The samples used are from volunteers who received the malaria vaccine FMP2.1/AS02A or a control (rabies vaccine), during a vaccine efficacy field trial, and who later developed malaria. In a previous study, P. falciparum DNA was extracted from all samples, and the ama1 locus amplified and sequenced. Here, a sieve analysis was used to measure T and B-cell escape, and difference in 3D7-like epitopes in the two treatment arms. Overall, no difference was observed in mean amino acid distance to the 3D7 AMA1 variant between sequences from vaccinees and controls in B-cell epitopes. However, we found a significantly greater proportion of 3D7-like T-cell epitopes that map to the AMA1 cluster one loop (c1L) region in the control vs. the vaccinee group (p = 0.02), consistent with allele-specific vaccine efficacy. Interestingly, AMA1 epitopes in infections from vaccinees had higher mean IC50, and consequently lower binding affinity, than epitopes generated from the control group (p = 0.01), suggesting that vaccine-induced selection impacted the immunological profile of the strains that pass through the sieve imposed by the vaccine-induced protection. These findings are consistent with a vaccine-derived sieve effect on the c1L region of AMA1 and suggest that sieve analyses of malaria vaccine trial samples targeted to epitopes identified in silico can help identify protective malaria antigens that may be efficacious if combined in a multivalent vaccine." @default.
• W3036457434 created "2020-06-25" @default.
• W3036457434 creator A5000332288 @default.
• W3036457434 creator A5011546643 @default.
• W3036457434 creator A5015868385 @default.
• W3036457434 creator A5018146103 @default.
• W3036457434 creator A5024467013 @default.
• W3036457434 creator A5029379996 @default.
• W3036457434 creator A5032921539 @default.
• W3036457434 creator A5035600540 @default.
• W3036457434 creator A5037505893 @default.
• W3036457434 creator A5053671869 @default.
• W3036457434 creator A5062058832 @default.
• W3036457434 creator A5062347440 @default.
• W3036457434 creator A5066635321 @default.
• W3036457434 creator A5070313672 @default.
• W3036457434 creator A5072014280 @default.
• W3036457434 creator A5079154906 @default.
• W3036457434 creator A5080059700 @default.
• W3036457434 date "2020-07-01" @default.
• W3036457434 modified "2023-10-17" @default.
• W3036457434 title "Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants" @default.
• W3036457434 cites W1966607693 @default.
• W3036457434 cites W1986576600 @default.
• W3036457434 cites W199440824 @default.
• W3036457434 cites W2005120335 @default.
• W3036457434 cites W2005335622 @default.
• W3036457434 cites W2006108716 @default.
• W3036457434 cites W2026745968 @default.
• W3036457434 cites W2028101850 @default.
• W3036457434 cites W2029851868 @default.
• W3036457434 cites W2039342073 @default.
• W3036457434 cites W2040345478 @default.
• W3036457434 cites W2063998825 @default.
• W3036457434 cites W2079792142 @default.
• W3036457434 cites W2085835971 @default.
• W3036457434 cites W2097874743 @default.
• W3036457434 cites W2107379480 @default.
• W3036457434 cites W2113495688 @default.
• W3036457434 cites W2122779464 @default.
• W3036457434 cites W2123169315 @default.
• W3036457434 cites W2123830992 @default.
• W3036457434 cites W2126092201 @default.
• W3036457434 cites W2140971235 @default.
• W3036457434 cites W2166902938 @default.
• W3036457434 cites W2172162021 @default.
• W3036457434 cites W2174831147 @default.
• W3036457434 cites W2289977218 @default.
• W3036457434 cites W2403121160 @default.
• W3036457434 cites W2536962927 @default.
• W3036457434 cites W2571810950 @default.
• W3036457434 cites W2587907012 @default.
• W3036457434 cites W2754855881 @default.
• W3036457434 cites W2768707191 @default.
• W3036457434 cites W2791741332 @default.
• W3036457434 cites W2799524357 @default.
• W3036457434 cites W2811381381 @default.
• W3036457434 cites W2900127803 @default.
• W3036457434 cites W2953065444 @default.
• W3036457434 cites W4317926802 @default.
• W3036457434 cites W2064023194 @default.
• W3036457434 doi "https://doi.org/10.1016/j.vaccine.2020.06.035" @default.
• W3036457434 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7375901" @default.
• W3036457434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32571720" @default.
• W3036457434 hasPublicationYear "2020" @default.
• W3036457434 type Work @default.
• W3036457434 sameAs 3036457434 @default.
• W3036457434 citedByCount "5" @default.
• W3036457434 countsByYear W30364574342021 @default.
• W3036457434 countsByYear W30364574342022 @default.
• W3036457434 countsByYear W30364574342023 @default.
• W3036457434 crossrefType "journal-article" @default.
• W3036457434 hasAuthorship W3036457434A5000332288 @default.
• W3036457434 hasAuthorship W3036457434A5011546643 @default.
• W3036457434 hasAuthorship W3036457434A5015868385 @default.
• W3036457434 hasAuthorship W3036457434A5018146103 @default.
• W3036457434 hasAuthorship W3036457434A5024467013 @default.
• W3036457434 hasAuthorship W3036457434A5029379996 @default.
• W3036457434 hasAuthorship W3036457434A5032921539 @default.
• W3036457434 hasAuthorship W3036457434A5035600540 @default.
• W3036457434 hasAuthorship W3036457434A5037505893 @default.
• W3036457434 hasAuthorship W3036457434A5053671869 @default.
• W3036457434 hasAuthorship W3036457434A5062058832 @default.
• W3036457434 hasAuthorship W3036457434A5062347440 @default.
• W3036457434 hasAuthorship W3036457434A5066635321 @default.
• W3036457434 hasAuthorship W3036457434A5070313672 @default.
• W3036457434 hasAuthorship W3036457434A5072014280 @default.
• W3036457434 hasAuthorship W3036457434A5079154906 @default.
• W3036457434 hasAuthorship W3036457434A5080059700 @default.
• W3036457434 hasBestOaLocation W30364574341 @default.
• W3036457434 hasConcept C147483822 @default.
• W3036457434 hasConcept C159047783 @default.
• W3036457434 hasConcept C195616568 @default.
• W3036457434 hasConcept C203014093 @default.
• W3036457434 hasConcept C22070199 @default.
• W3036457434 hasConcept C2522874641 @default.
• W3036457434 hasConcept C2777961786 @default.
• W3036457434 hasConcept C2778048844 @default.

• next